title	geo_accession	status	submission_date	last_update_date	type	channel_count	source_name_ch1	organism_ch1	characteristics_ch1	characteristics_ch1.1	characteristics_ch1.2	treatment_protocol_ch1	growth_protocol_ch1	molecule_ch1	extract_protocol_ch1	extract_protocol_ch1.1	taxid_ch1	description	data_processing	data_processing.1	data_processing.2	data_processing.3	data_processing.4	data_processing.5	data_processing.6	platform_id	contact_name	contact_email	contact_phone	contact_department	contact_institute	contact_address	contact_city	contact_zip/postal_code	contact_country	data_row_count	instrument_model	library_selection	library_source	library_strategy	relation	relation.1	supplementary_file_1	cell type:ch1	genotype:ch1	tissue:ch1
Genetically correction of Down syndrome_1	GSM6165373	Public on May 20 2022	May 18 2022	May 20 2022	SRA	1	iPS derived EC	Homo sapiens	tissue: iPS derived EC	cell type: endothelial cells	genotype: WT	Each iPSC line was differentiated to ECs by using MiraCell iPS Cell to Endothelial Cell Differentiation Kit (Takara bio) following the manufacturer's protocol.	iPSC-derived ECs were maintained in MiraCell EC Culture Medium (Takara bio) with antibiotics in humidified atmosphere with 5% CO2 at 37C.	total RNA	RNA was extracted using NucleoSpin (Takara Bio) following the manufacturer’s procedure.	Library preparation was performed using the TruSeq stranded mRNA sample prep kit (Illumina).	9606	EC_cDi21	An Illumina HiSeq 2500 platform in 75-base single-end mode was used for sequencing.	Illumina CASAVA 1.8.2 software was used for base calling.	Sequenced reads were mapped to the human reference genome sequence (hg19) using TopHat version 2.0.13 in combination with Bowtie2 version 2.2.3 and SAMtools version 0.1.19.	Fragments per kilobase of exon per million mapped fragments were calculated using Cuffnorm version 2.2.1.	Ingenuity Pathway Analysis was used to identify canonical pathways of differentially expressed genes.	Assembly: hg19	Supplementary files format and content: tab-delimited text files include FPKM values for each Sample	GPL16791	Hidehiro,,Suginobe	hdhrsgnb@gmail.com	81668793932	Pediatrics	Osaka University	2-2, Yamadaoka	Sutia	565-0871	Japan	0	Illumina HiSeq 2500	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN28522292	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX15324720	NONE	endothelial cells	WT	iPS derived EC
Healthy control_1	GSM6165374	Public on May 20 2022	May 18 2022	May 20 2022	SRA	1	iPS derived EC	Homo sapiens	tissue: iPS derived EC	cell type: endothelial cells	genotype: WT	Each iPSC line was differentiated to ECs by using MiraCell iPS Cell to Endothelial Cell Differentiation Kit (Takara bio) following the manufacturer's protocol.	iPSC-derived ECs were maintained in MiraCell EC Culture Medium (Takara bio) with antibiotics in humidified atmosphere with 5% CO2 at 37C.	total RNA	RNA was extracted using NucleoSpin (Takara Bio) following the manufacturer’s procedure.	Library preparation was performed using the TruSeq stranded mRNA sample prep kit (Illumina).	9606	EC_HC_1	An Illumina HiSeq 2500 platform in 75-base single-end mode was used for sequencing.	Illumina CASAVA 1.8.2 software was used for base calling.	Sequenced reads were mapped to the human reference genome sequence (hg19) using TopHat version 2.0.13 in combination with Bowtie2 version 2.2.3 and SAMtools version 0.1.19.	Fragments per kilobase of exon per million mapped fragments were calculated using Cuffnorm version 2.2.1.	Ingenuity Pathway Analysis was used to identify canonical pathways of differentially expressed genes.	Assembly: hg19	Supplementary files format and content: tab-delimited text files include FPKM values for each Sample	GPL16791	Hidehiro,,Suginobe	hdhrsgnb@gmail.com	81668793932	Pediatrics	Osaka University	2-2, Yamadaoka	Sutia	565-0871	Japan	0	Illumina HiSeq 2500	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN28522291	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX15324721	NONE	endothelial cells	WT	iPS derived EC
Healthy control_2	GSM6165375	Public on May 20 2022	May 18 2022	May 20 2022	SRA	1	iPS derived EC	Homo sapiens	tissue: iPS derived EC	cell type: endothelial cells	genotype: WT	Each iPSC line was differentiated to ECs by using MiraCell iPS Cell to Endothelial Cell Differentiation Kit (Takara bio) following the manufacturer's protocol.	iPSC-derived ECs were maintained in MiraCell EC Culture Medium (Takara bio) with antibiotics in humidified atmosphere with 5% CO2 at 37C.	total RNA	RNA was extracted using NucleoSpin (Takara Bio) following the manufacturer’s procedure.	Library preparation was performed using the TruSeq stranded mRNA sample prep kit (Illumina).	9606	EC_HC_2	An Illumina HiSeq 2500 platform in 75-base single-end mode was used for sequencing.	Illumina CASAVA 1.8.2 software was used for base calling.	Sequenced reads were mapped to the human reference genome sequence (hg19) using TopHat version 2.0.13 in combination with Bowtie2 version 2.2.3 and SAMtools version 0.1.19.	Fragments per kilobase of exon per million mapped fragments were calculated using Cuffnorm version 2.2.1.	Ingenuity Pathway Analysis was used to identify canonical pathways of differentially expressed genes.	Assembly: hg19	Supplementary files format and content: tab-delimited text files include FPKM values for each Sample	GPL16791	Hidehiro,,Suginobe	hdhrsgnb@gmail.com	81668793932	Pediatrics	Osaka University	2-2, Yamadaoka	Sutia	565-0871	Japan	0	Illumina HiSeq 2500	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN28522290	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX15324722	NONE	endothelial cells	WT	iPS derived EC
Down syndrome_1	GSM6165376	Public on May 20 2022	May 18 2022	May 20 2022	SRA	1	iPS derived EC	Homo sapiens	tissue: iPS derived EC	cell type: endothelial cells	genotype: 21 trisomy	Each iPSC line was differentiated to ECs by using MiraCell iPS Cell to Endothelial Cell Differentiation Kit (Takara bio) following the manufacturer's protocol.	iPSC-derived ECs were maintained in MiraCell EC Culture Medium (Takara bio) with antibiotics in humidified atmosphere with 5% CO2 at 37C.	total RNA	RNA was extracted using NucleoSpin (Takara Bio) following the manufacturer’s procedure.	Library preparation was performed using the TruSeq stranded mRNA sample prep kit (Illumina).	9606	EC_T21	An Illumina HiSeq 2500 platform in 75-base single-end mode was used for sequencing.	Illumina CASAVA 1.8.2 software was used for base calling.	Sequenced reads were mapped to the human reference genome sequence (hg19) using TopHat version 2.0.13 in combination with Bowtie2 version 2.2.3 and SAMtools version 0.1.19.	Fragments per kilobase of exon per million mapped fragments were calculated using Cuffnorm version 2.2.1.	Ingenuity Pathway Analysis was used to identify canonical pathways of differentially expressed genes.	Assembly: hg19	Supplementary files format and content: tab-delimited text files include FPKM values for each Sample	GPL16791	Hidehiro,,Suginobe	hdhrsgnb@gmail.com	81668793932	Pediatrics	Osaka University	2-2, Yamadaoka	Sutia	565-0871	Japan	0	Illumina HiSeq 2500	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN28522289	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX15324723	NONE	endothelial cells	21 trisomy	iPS derived EC
Down syndrome_2	GSM6165377	Public on May 20 2022	May 18 2022	May 20 2022	SRA	1	iPS derived EC	Homo sapiens	tissue: iPS derived EC	cell type: endothelial cells	genotype: 21 trisomy	Each iPSC line was differentiated to ECs by using MiraCell iPS Cell to Endothelial Cell Differentiation Kit (Takara bio) following the manufacturer's protocol.	iPSC-derived ECs were maintained in MiraCell EC Culture Medium (Takara bio) with antibiotics in humidified atmosphere with 5% CO2 at 37C.	total RNA	RNA was extracted using NucleoSpin (Takara Bio) following the manufacturer’s procedure.	Library preparation was performed using the TruSeq stranded mRNA sample prep kit (Illumina).	9606	EC_T21'	An Illumina HiSeq 2500 platform in 75-base single-end mode was used for sequencing.	Illumina CASAVA 1.8.2 software was used for base calling.	Sequenced reads were mapped to the human reference genome sequence (hg19) using TopHat version 2.0.13 in combination with Bowtie2 version 2.2.3 and SAMtools version 0.1.19.	Fragments per kilobase of exon per million mapped fragments were calculated using Cuffnorm version 2.2.1.	Ingenuity Pathway Analysis was used to identify canonical pathways of differentially expressed genes.	Assembly: hg19	Supplementary files format and content: tab-delimited text files include FPKM values for each Sample	GPL16791	Hidehiro,,Suginobe	hdhrsgnb@gmail.com	81668793932	Pediatrics	Osaka University	2-2, Yamadaoka	Sutia	565-0871	Japan	0	Illumina HiSeq 2500	cDNA	transcriptomic	RNA-Seq	BioSample: https://www.ncbi.nlm.nih.gov/biosample/SAMN28522288	SRA: https://www.ncbi.nlm.nih.gov/sra?term=SRX15324724	NONE	endothelial cells	21 trisomy	iPS derived EC
